BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1809075)

  • 1. Steroid receptor assays: an Italian quality assessment program.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
    Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].
    Goussard J
    Bull Cancer; 1996 Dec; 83(12):1031-6. PubMed ID: 9116370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
    Dittadi R; Meo S; Amoroso B; Gion M
    Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networks.
    Le Goff JM; Lavayssière L; Rouëssé J; Spyratos F
    Anticancer Res; 2000; 20(3B):2213-8. PubMed ID: 10928180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer].
    Ohnami S; Nakayama C; Ohnami S; Zeze F; Eto S
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3447-52. PubMed ID: 3539025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States.
    Jordan VC; Jacobson HI; Keenan EJ
    Cancer Res; 1986 Aug; 46(8 Suppl):4237s-4240s. PubMed ID: 3524804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
    Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
    Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
    Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
    Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
    Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunohistochemical detection of steroid hormone receptors in breast cancer: open problems and new perspectives].
    Barbareschi M; Doglioni C
    Pathologica; 2002 Jun; 94(3):115-20. PubMed ID: 12108031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
    Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
    Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control study for estradiol receptor determination.
    Számel I; Vermousek I
    Arch Geschwulstforsch; 1985; 55(3):187-92. PubMed ID: 4026532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects in histopathological assessment of breast cancer].
    Sastre X
    Bull Cancer; 1997 Jan; 84(1):65-8. PubMed ID: 9180862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
    Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.